Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737281 · ClinicalTrials.gov registry record · NA
Proactive Outreach for Smokers in VA Mental Health
A NA study of Smoking, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 1,938
- Enrollment target
- 4
- Study locations
NCT01737281: Completed NA study of Smoking, sponsored by VA Office of Research and Development.
NCT01737281 is a NA study of Smoking that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,938 participants, above the 439-participant average among 123 other Smoking trials with a reported enrollment target (341% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01737281, a NA study of Smoking, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,938 participants
- Enrollment target
- 4
- Study locations
Study Summary
Veterans with a mental health diagnosis have higher a prevalence of smoking and higher rates of smoking-related morbidities compared to the general Veteran population. Smoking cessation treatment delivery in the VA typically depends on a visit from a health care provider. In this study, investigators will use information within the electronic medical record to identify all smokers with a mental health diagnosis at a VA health care facility and proactively reach out to enroll them in an intensive tobacco cessation treatment program. This approach could be generalized to other behaviors and provides a novel method to improve the health of an entire population of patients.
Primary Outcome
The primary outcome will be cotinine-validated abstinence from smoking at 12-month follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Proactive outreach
Study Locations (4)
Florida
- James A. Haley Veterans' Hospital, Tampa, FL - Tampa
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
New York
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY - New York
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,938 participants |
| Start Date | 2014-07-01 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT01737281 record still lists
NCT01737281 is an interventional study that assigns participants to a tested intervention. Its 1,938 participants enrollment target places it among the larger protocols in the corpus, above the 439-participant average among 123 other Smoking trials with a reported enrollment target (341% higher).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT01737281 reports a single indexed study location in Florida, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT01737281 about?
NCT01737281 is a clinical study titled "Proactive Outreach for Smokers in VA Mental Health". Veterans with a mental health diagnosis have higher a prevalence of smoking and higher rates of smoking-related morbidities compared to the general Veteran population. Smoking cessation treatment delivery in the VA typically depends on a visit from a health care provider. In this study, investigator...
What is the current status of trial NCT01737281?
This trial is currently completed. It is a NA study. The enrollment target is 1,938 participants. The study started on 2014-07-01. Estimated completion is 2018-06-30.
What conditions does trial NCT01737281 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT01737281?
The interventions under investigation include: Usual care (BEHAVIORAL), Proactive outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT01737281?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01737281 being conducted?
This trial has 4 study locations across Florida, Minnesota, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01737281's enrollment target sits among peer trials
1,938 8th of 123 higher than 116 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI